What this is
- How it works
- How it works isn't classified yet
- Tested for
- Impacted Third Molar Tooth, Tooth Extraction Status Nos
- Main trialPhase 2
- “This is a single center, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of MAX-001 in participants with post-operative dental pain after wisdom teeth removal.”In the company’s words, NCT07937657 on ClinicalTrials.gov
Coming up1
- Jun 2027Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 16 NovNew trial: none to Phase 2 · ClinicalTrials.gov NCT07937657
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | Jun 2027 | A Study to Evaluate the Safety and Pain Relief of MAX-001 After Surgical Removal of Wisdom Teeth |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026